Skip to content
★ Sign in to follow
JK

J. Kimo Esplin

CFO
Huntsman CorpNutraceutical International CorpWatkins Johnson Co Employee Stock Option
Total declarations
205
Companies
3
▲ Purchases (37 ops.)
€236k
▼ Sales (21 ops.)
€22.7M

Latest filing published 03 Aug 2018 for Huntsman CORP.

Filing timeline

BuySale
J. Kimo Esplin

Insider track record

Disclosed buys
37
Disclosed sells
21
Signal history

Closed purchases

Market purchases
37
Positive at T+90
0%
Median T+90
-9.1%

Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 21 Aug 2015 · 4097 days ago · €74k
    +5.7%
    Entry US$16.05 · Close at T+365 US$16.96
  • Filed 17 Dec 2008 · 6535 days ago · €34k
    +223.1%
    Entry US$3.46 · Close at T+365 US$11.18
  • Filed 27 Feb 2008 · 6829 days ago · €69k
    -87.0%
    Entry US$24.13 · Close at T+365 US$3.13

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

J. Kimo Esplin: trading record in brief

Filings by J. Kimo Esplin span 3 companies, the busiest being Nutraceutical International Corp, Huntsman Corp and Watkins Johnson Co Employee Stock Option. In total, 205 filings cover trades dated from 10 February 2006 to 16 May 2018.

The open-market side counts 37 purchases for €236k alongside 21 sales for €22.7M. The amount is not disclosed for 1 filing. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 133 share grants and 12 option exercises. So far in 2018, the count stands at no purchases and 3 sales.

Half of the purchases are above €726 and half below. Looking at 5 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -9.1%. These figures describe past trades and do not predict future prices.

The record was last updated on 3 August 2018 with a transaction in Huntsman Corp. The last insider purchase was made public on 21 August 2015, 4,097 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to J. Kimo Esplin

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations189 total
  • ●
    Exec VP, Strategy & InvestmentExecutivesHuntsman Corp
    0SEC
    13,657 shares0Common StockSEC:0001214659-18-005214:0
  • ▼
    Exec VP, Strategy & InvestmentExecutivesHuntsman Corp
    163,650 USD11SEC
    5,000 shares@ US$32.730.5% of flowCommon StockSEC:0001214659-18-003862:0
  • ▼
    Exec VP, Strategy & InvestmentExecutivesHuntsman Corp
    362,833 USD11SEC
    11,106 shares@ US$32.671.1% of flowCommon StockSEC:0001214659-18-003862:1
  • ▼
    Exec VP, Strategy & InvestmentExecutivesHuntsman Corp
    1M USD11SEC
    34,399 shares@ US$31.813.2% of flowCommon StockSEC:0001214659-18-003840:0
  • ◆
    Exec VP, Strategy & InvestmentExecutivesHuntsman Corp
    0SEC
    4,993 shares0Common StockSEC:0001214659-18-001064:0
  • ◆
    Exec VP, Strategy & InvestmentExecutivesHuntsman Corp
    0SEC
    1,466 shares0Common StockSEC:0001214659-18-001064:1
  • ◆
    Exec VP, Strategy & InvestmentExecutivesHuntsman Corp
    160,742 USD11SEC
    4,952 shares@ US$32.460.5% of flowCommon StockSEC:0001214659-18-000913:0
  • ◆
    Exec VP, Strategy & InvestmentExecutivesHuntsman Corp
    72,548 USD11SEC
    2,235 shares@ US$32.460.2% of flowCommon StockSEC:0001214659-18-000913:1
  • ◇
    Exec VP, Strategy & InvestmentExecutivesHuntsman Corp
    434,552 USD11SEC
    32,189 shares@ US$13.501.3% of flowCommon StockSEC:0001214659-17-007215:0
  • ▼
    Exec VP, Strategy & InvestmentExecutivesHuntsman Corp
    1M USD26SEC
    32,189 shares@ US$31.283.0% of flowCommon StockSEC:0001214659-17-007215:1
  • ◇
    Exec VP, Strategy & InvestmentExecutivesHuntsman Corp
    1M USD11SEC
    75,758 shares@ US$17.854.0% of flowCommon StockSEC:0001214659-17-007215:2
  • ▼
    Exec VP, Strategy & InvestmentExecutivesHuntsman Corp
    2M USD27SEC
    75,758 shares@ US$31.317.1% of flowCommon StockSEC:0001214659-17-007215:3
  • ◇
    Exec VP, Strategy & InvestmentExecutivesHuntsman Corp
    791,217 USD11SEC
    59,002 shares@ US$13.412.4% of flowCommon StockSEC:0001214659-17-007215:4
  • ▼
    Exec VP, Strategy & InvestmentExecutivesHuntsman Corp
    2M USD27SEC
    59,002 shares@ US$31.355.5% of flowCommon StockSEC:0001214659-17-007215:5
  • ◇
    Exec VP, Strategy & InvestmentExecutivesHuntsman Corp
    263,024 USD11SEC
    19,614 shares@ US$13.410.8% of flowCommon StockSEC:0001214659-17-007215:6
  • ▼
    Exec VP, Strategy & InvestmentExecutivesHuntsman Corp
    593,324 USD26SEC
    19,614 shares@ US$30.251.8% of flowCommon StockSEC:0001214659-17-007215:7
  • ◇
    Exec VP, Strategy & InvestmentExecutivesHuntsman Corp
    953,906 USD11SEC
    54,230 shares@ US$17.592.8% of flowCommon StockSEC:0001214659-17-007215:8
  • ▼
    Exec VP, Strategy & InvestmentExecutivesHuntsman Corp
    2M USD26SEC
    54,230 shares@ US$30.254.9% of flowCommon StockSEC:0001214659-17-007215:9
  • ◇
    Exec VP, Strategy & InvestmentExecutivesHuntsman Corp
    1M USD11SEC
    428,571 shares@ US$2.593.4% of flowCommon StockSEC:0001214659-17-006302:0
  • ▼
    Exec VP, Strategy & InvestmentExecutivesHuntsman Corp
    14M USD33SEC
    428,571 shares@ US$31.5441.1% of flowCommon StockSEC:0001214659-17-006302:1
  • ●
    DirectorExecutivesNutraceutical International Corp
    0SEC
    11,127.48 sharesCommon StockSEC:0001396677-17-000037:0
  • ◆
    DirectorExecutivesNutraceutical International Corp
    1,000 USD12SEC
    31.77 shares@ US$31.486.3% of flowCommon StockSEC:0001396677-17-000022:0
  • ◆
    DirectorExecutivesNutraceutical International Corp
    1,000 USD12SEC
    32.39 shares@ US$30.886.4% of flowCommon StockSEC:0001396677-17-000017:0
  • ◆
    DirectorExecutivesNutraceutical International Corp
    1,000 USD12SEC
    29.09 shares@ US$34.386.5% of flowCommon StockSEC:0001396677-17-000010:0
  • ◇
    Exec VP, Strategy & InvestmentExecutivesHuntsman Corp
    2M USD12SEC
    110,663 shares@ US$20.667.6% of flowCommon StockSEC:0001214659-17-001284:0

25 of 189 declarations